# Gene Therapy for Patients With Leukocyte Adherence Deficiency (Follow-Up of Phase 1 Trial)

> **NCT00023010** · — · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 2 (actual)

## Conditions studied

- Leukocyte Adhesion Deficiency Syndrome

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00023010
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2001-08-15
- **Primary completion:** —
- **Final completion:** 2010-12-13
- **Target enrollment:** 2 (ACTUAL)
- **Last updated:** 2017-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00023010

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00023010, "Gene Therapy for Patients With Leukocyte Adherence Deficiency (Follow-Up of Phase 1 Trial)". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT00023010. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*